Human Papillomavirus Type 16 and TP53 Mutation in Oral Cancer: Matched Analysis of the IARC Multicenter Study

Cancer Research

Volumn 64, Issue 2, 2004, Pages 468-471

  Dai, Min ^a   Clifford, Gary M ^a   Le Calvez, Florence ^a   Castellsagué, Xavier ^b   Snijders, Peter J F ^c   Pawlita, Michael ^d   Herrero, Rolando ^a,e   Hainaut, Pierre ^a   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e Costa Rican Found for Hlth Sci ^*  (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN P53; VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIBODY DETECTION; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MOUTH CANCER; MOUTH CAVITY; MULTICENTER STUDY; NONHUMAN; OROPHARYNX; PRIORITY JOURNAL; SMOKING; TUMOR SUPPRESSOR GENE; WART VIRUS;

BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; DNA, VIRAL; FEMALE; GEOGRAPHY; HUMANS; MALE; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1642515808     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3284     Document Type: Article

References (23)

1. Ringstrom, E., Peters, E., Hasegawa, M., Posner, M., Liu, M., and Kelsey, K. T. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin. Cancer Res., 8: 3187-3192, 2002.
2. Herrero, R., Castellsague, X., Pawlita, M., Lissowska, J., Kee, F., Balaram, P., Rajkumar, T., Sridhar, H., Rose, B., Pintos, J., Fernandez, L., Idris, A. M., Sanchez, M. J., Nieto, A., Talamini, R., Tavani, A., Bosch, F. X., Reidel, U., Snijders, P., Meijer, C., Viscidi, R., Muñoz, N., and Franceschi, S. The viral etiology of oral cancer: evidence from the IARC multi-center study. J. Natl. Cancer Inst. (Bethesda), 95: 1772-1783, 2003.
3. Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., Zahurak, M. L., Daniel, R. W., Viglione, M., Symer, D. E., Shah, K. V., and Sidransky, D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. (Bethesda), 92: 709-720, 2000.
4. Schwartz, S. M., Daling, J. R., Doody, D. R., Wipf, G. C., Carter, J. J., Madeleine, M. M., Mao, E. J., Fitzgibbons, E. D., Huang, S., Beckmann, A. M., McDougall, J. K., and Galloway, D. A. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J. Natl. Cancer Inst. (Bethesda), 90: 1626-1636, 1998.
5. Franceschi, S., Munoz, N., Bosch, X. F., Snijders, P. J., and Walboomers, J. M. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol. Biomark. Prev., 5: 567-575, 1996.
6. Gillison, M. L., and Shah, K. V. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr. Opin. Oncol., 13: 183-188, 2001.
7. Snijders, P. J., Steenbergen, R. D., Meijer, C. J., and Walboomers, J. M. Role of human papillomaviruses in cancer of the respiratory and upper digestive tract. Clin. Dermatol., 15: 415-425, 1997.
8. Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., and Franceschi, S. Human papillomavirus types in invasive cancer worldwide: a meta-analysis. Br. J. Cancer, 88: 63-73, 2003.
9. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses, Vol. 64. Lyon, France: IARC, 1995.
10. McDougall, J. K. Immortalization and transformation of human cells by human papillomavirus. Curr. Top. Microbiol. Immunol., 186: 101-119, 1994.
11. Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., and Hainaut, P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum. Mutat., 19: 607-614, 2002.
12. Franceschi, S., Levi, F., La Vecchia, C., Conti, E., Dal Maso, L., Barzan, L., and Talamini, R. Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer. Int. J. Cancer, 83: 1-4, 1999.
13. Balaram, P., Sridhar, H., Rajkumar, T., Vaccarella, S., Herrero, R., Nandakumar, A., Ravichandran, K., Ramdas, K., Sankaranarayanan, R., Gajalakshmi, V., Munoz, N., and Franceschi, S. Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int. J. Cancer, 98: 440-445, 2002.
14. van Houten, V. M., Snijders, P. J., van den Brekel, M. W., Kummer, J. A., Meijer, C. J., van Leeuwen, B., Denkers, F., Smeele, L. E., Snow, G. B., and Brakenhoff, R. H. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int. J. Cancer, 93: 232-235, 2001.
15. Sehr, P., Zumbach, K., and Pawlita, M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J. Immunol. Methods, 253: 153-162, 2001.
16. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research, Vol. I. The Analysis of Case-Control Studies. IARC Scientific Publication No. 165-169. Lyon, France: IARC, 1980.
17. Dong, S. M., Sun, D. I., Benoit, N. E., Kuzmin, I., Lerman, M. I., and Sidransky, D. Epigenetic inactivation of RASSFIA in head and neck cancer. Clin. Cancer Res., 9: 3635-3640, 2003.
18. Snijders, P. J., Steenbergen, R. D., Top, B., Scott, S. D., Meijer, C. J., and Walboomers, J. M. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J. Gen. Virol., 75: 2769-2775, 1994.
19. Wiest, T., Schwarz, E., Enders, C., Flechtenmacher, C., and Bosch, F. X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene, 21: 1510-1517, 2002.
20. Pfeifer, G. P., Denissenko, M. F., Olivier, M., Tretyakova, N., Hecht, S. S., and Hainaut, P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene, 21: 7435-7451, 2002.
21. Meschede, W., Zumbach, K., Braspenning, J., Scheffner, M., Benitez-Bribiesca, L., Luande, J., Gissmann, L., and Pawlita, M. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J. Clin. Microbiol., 36: 475-480, 1998.
22. Tommasino, M., and Crawford, L. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle. Bioessays, 17: 509-518, 1995.
23. Galloway, D. A. Papillomavirus vaccines in clinical trials. Lancet Infect. Dis., 3: 469-475, 2003.